These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20109612)

  • 41. Extending cord blood transplant to adults: dealing with problems and results overall.
    Brunstein CG; Laughlin MJ
    Semin Hematol; 2010 Jan; 47(1):86-96. PubMed ID: 20109616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Wang JZ; Gao ZY; Zhang YC; Jiang Q; Shi HX; Lu DP
    Bone Marrow Transplant; 2006 Aug; 38(4):291-7. PubMed ID: 16883312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current status and development of hematopoietic stem cell transplantation in China: a report from Chinese Hematopoietic Stem Cell Transplantation Register Group.
    Xu LP; Huang XJ
    Chin Med J (Engl); 2011 Aug; 124(16):2548-55. PubMed ID: 21933603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft.
    di Grazia C; Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Berisso G; Bregante S; Dominietto A; Mordini N; Bruno B; Frassoni F; Bacigalupo A
    Haematologica; 2001 Jun; 86(6):646-51. PubMed ID: 11418375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
    J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strategies of the donor search for children with second CR ALL lacking a matched sibling donor.
    Lanino E; Sacchi N; Peters C; Giardino S; Rocha V; Dini G; ;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S75-9. PubMed ID: 18545249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors.
    Cairo MS; Rocha V; Gluckman E; Hale G; Wagner J
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):44-53. PubMed ID: 18162220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
    Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors.
    Rocha V; Gluckman E;
    Br J Haematol; 2009 Oct; 147(2):262-74. PubMed ID: 19796275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
    Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
    J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haploidentical stem cell transplantation in leukemia.
    Aversa F; Velardi A; Tabilio A; Reisner Y; Martelli MF
    Blood Rev; 2001 Sep; 15(3):111-9. PubMed ID: 11735159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Haploidentical stem cell transplantation as a salvage therapy for cord blood engraftment failure in a patient with Fanconi anemia.
    Rihani R; Lataifeh I; Halalsheh H; Hussein AA; Al-Zaben A; Abdel-Rahman F; Sarhan M
    Pediatr Blood Cancer; 2010 Sep; 55(3):580-2. PubMed ID: 20658637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unrelated umbilical cord blood unit selection.
    Scaradavou A;
    Semin Hematol; 2010 Jan; 47(1):13-21. PubMed ID: 20109608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stem cell source and outcome after hematopoietic stem cell transplantation (HSCT) in children and adolescents with acute leukemia.
    Peters C; Cornish JM; Parikh SH; Kurtzberg J
    Pediatr Clin North Am; 2010 Feb; 57(1):27-46. PubMed ID: 20307710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
    Kindwall-Keller TL; Ballen KK
    Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Algorithm for donor selection in 2011.
    Arcese W; Mangione I; Picardi A
    Curr Opin Hematol; 2011 Nov; 18(6):401-7. PubMed ID: 21946072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.